Discovery may lead to targeted melanoma therapies
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published ...
Jun 17, 2015
0
28